Equity
-€151,542
Debts exceed assets in financial year 2025.
PLUS PHARMA
Lifetime
16 annual accounts with figures on one time axispeak €33,612 (2014)
-€923▼ €12
lowest -€55,871 (2015)
-€1,825▲ €17
peak -€5,592 (2014)
-€151,542▼ €1,825
€152,550▲ 0.7%
Documentsfilings and deeds
02-02-20262 days late
2025financial year
Loss of €1,825Cash from €1,314 to €484
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,920 companies had the same profile as PLUS PHARMA has now. Each dot stands for 18 companies, two years later.
85.3%
were still trading
8.3%
stopped another way
5.8%
went bankrupt
Another 0.6% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,920 companies, not a prediction for PLUS PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0811970964
First establishment
Industriestrasse 38, Eupen
Incorporation
published on 08-06-2009 · Gazette deed
Official details
Source: KBO- Status
- Active since 28-05-2009Normal situation
- Registered office
- 30 active companies are registered at this address3 started in the 12 months before. Source: KBO register, as of 15 November 2026.
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.178.468.0654700 Eupen, since 08-06-2009
- Financial year end
- 30 June
- Peppol
- Reachable since 15-04-2026
Insights on PLUS PHARMA
The gross margin has fallen every year since 2022.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PLUS PHARMA
- What is the company number of PLUS PHARMA?
- The company number of PLUS PHARMA is 0811.970.964. The VAT number is the same number with BE in front: BE 0811.970.964.
- Where is PLUS PHARMA based?
- The registered office is at Industriestrasse 38, 4700 Eupen.Company details
- What is the legal form of PLUS PHARMA?
- PLUS PHARMA is a private limited company (pre-2019) (BVBA).
- When was PLUS PHARMA founded?
- PLUS PHARMA was founded on 28-05-2009.
- Is PLUS PHARMA still active?
- Yes, PLUS PHARMA is an active enterprise in the KBO register.
- What is the turnover of PLUS PHARMA?
- The annual accounts for financial year 2025 state no turnover.Financials
- Is PLUS PHARMA profitable?
- In financial year 2025, PLUS PHARMA made a loss of €1,825.
- Where can I find the annual accounts of PLUS PHARMA?
- PLUS PHARMA filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PLUS PHARMA due?
- PLUS PHARMA must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.